SELLAS Life Sciences Gr Q3 EPS $(0.05), Inline

Benzinga · 1d ago
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.